Evidence map›Paper›PMID 33862009›Full record

SynthesisThe Journal of allergy and clinical immunology2021

Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis.

Nandinee Patel, Kok Wee Chong, Alexander Y G Yip, Despo Ierodiakonou, Joan Bartra, Robert J Boyle, Paul J Turner

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of allergy and clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. 2025 Korean Guidelines for Cardiopulmonary Resuscitation: Part 11. First aid.Clinical and experimental emergency medicine · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Successful treatment of refractory anaphylactic shock with angiotensin II: A case report.European journal of anaesthesiology and intensive care · 2026
    Article
  9. Biphasic, Refractory, and Persistent Anaphylaxis in Children.Clinical and translational allergy · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Lactate in Anaphylaxis: 100 Years On.Sports medicine (Auckland, N.Z.) · 2025
    Review
  15. Emergency Monitoring Following A Diagnosis of Anaphylaxis.Current allergy and asthma reports · 2025
    Review
  16. Review
  17. Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
  18. Anaphylactic Shock Caused by Eating Buckwheat.Journal of clinical medicine · 2024
    Article
  19. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nandinee PatelNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Kok Wee ChongAllergy Service, Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore.
Alexander Y G YipSchool of Medicine, Imperial College London, London, United Kingdom.
Despo IerodiakonouDepartment of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
Joan BartraHospital Clínic de Barcelona, Barcelona, Spain.
Robert J BoyleNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Paul J TurnerNational Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: p.turner@imperial.ac.uk.

Funding

Department of HealthMedical Research Council MR/K010468/1
6 · The paper itself

Abstract

backgroundRegulatory bodies recommend that all patients at risk of anaphylaxis be prescribed 2 epinephrine autoinjectors, which they should carry at all times. This is in contrast to some guidelines. The proportion of anaphylaxis reactions that are treated with multiple doses of epinephrine has not been systematically evaluated.

objectiveOur aim was to undertake a systematic review and meta-analysis of published studies reporting epinephrine treatment for anaphylaxis in which data relating to the number of doses administered were available.

methodsWe searched the Medline, Embase, and Cochrane databases for relevant studies reporting at least 10 anaphylaxis events (due to food or venom) from 1946 until January 2020. Data were extracted in duplicate for the meta-analysis, and the risk of bias was assessed. The study was registered under the PROSPERO identifier CRD42017069109.

resultsA total of 86 studies (36,557 anaphylaxis events) met the inclusion criteria (20 of the studies [23%] were prospective studies; 64 [74%] reported reactions in the community, and 22 [26%] included food challenge data). Risk of bias was assessed as low in 50 studies. Overall, 7.7% of anaphylaxis events from any cause (95% CI = 6.4-9.1) were treated with multiple doses of epinephrine. When only epinephrine-treated reactions for which subsequent doses were administered by a health care professional were considered, 11.1% of food-induced reactions (95% CI = 9.4-13.2) and 17.1% of venom-induced reactions (95% CI = 11.3-25.0) were treated with more than 1 epinephrine dose. Heterogeneity was moderate to high in the meta-analyses, but at sensitivity analysis this estimate was not affected by study design or anaphylaxis definition.

conclusionAround 1 in 10 anaphylaxis reactions are treated with more than 1 dose of epinephrine.

Indexed as

AnaphylaxisAnimalsBronchodilator AgentsClinical ProtocolsDrug Dosage CalculationsEpinephrineHumansHypersensitivityBronchodilator AgentsEpinephrineallergic reactionanaphylaxisautoinjector deviceEpinephrinerefractory anaphylaxis

Identifiers

PMID33862009
PMCPMC8588837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.